| Style | Citing Format |
|---|---|
| MLA | Sadeghi H, et al.. "Iron Oxyhydroxide Nanoparticles: Green Synthesis and Their Cytotoxicity Activity Against A549 Human Lung Adenocarcinoma Cells." Rendiconti Lincei, vol. 33, no. 2, 2022, pp. 461-469. |
| APA | Sadeghi H, Alijani HQ, Hashemishahraki S, Naderifar M, Rahimi SS, Zadeh FA, Iravani S, Haghighat M, Khatami M (2022). Iron Oxyhydroxide Nanoparticles: Green Synthesis and Their Cytotoxicity Activity Against A549 Human Lung Adenocarcinoma Cells. Rendiconti Lincei, 33(2), 461-469. |
| Chicago | Sadeghi H, Alijani HQ, Hashemishahraki S, Naderifar M, Rahimi SS, Zadeh FA, Iravani S, Haghighat M, Khatami M. "Iron Oxyhydroxide Nanoparticles: Green Synthesis and Their Cytotoxicity Activity Against A549 Human Lung Adenocarcinoma Cells." Rendiconti Lincei 33, no. 2 (2022): 461-469. |
| Harvard | Sadeghi H et al. (2022) 'Iron Oxyhydroxide Nanoparticles: Green Synthesis and Their Cytotoxicity Activity Against A549 Human Lung Adenocarcinoma Cells', Rendiconti Lincei, 33(2), pp. 461-469. |
| Vancouver | Sadeghi H, Alijani HQ, Hashemishahraki S, Naderifar M, Rahimi SS, Zadeh FA, et al.. Iron Oxyhydroxide Nanoparticles: Green Synthesis and Their Cytotoxicity Activity Against A549 Human Lung Adenocarcinoma Cells. Rendiconti Lincei. 2022;33(2):461-469. |
| BibTex | @article{ author = {Sadeghi H and Alijani HQ and Hashemishahraki S and Naderifar M and Rahimi SS and Zadeh FA and Iravani S and Haghighat M and Khatami M}, title = {Iron Oxyhydroxide Nanoparticles: Green Synthesis and Their Cytotoxicity Activity Against A549 Human Lung Adenocarcinoma Cells}, journal = {Rendiconti Lincei}, volume = {33}, number = {2}, pages = {461-469}, year = {2022} } |
| RIS | TY - JOUR AU - Sadeghi H AU - Alijani HQ AU - Hashemishahraki S AU - Naderifar M AU - Rahimi SS AU - Zadeh FA AU - Iravani S AU - Haghighat M AU - Khatami M TI - Iron Oxyhydroxide Nanoparticles: Green Synthesis and Their Cytotoxicity Activity Against A549 Human Lung Adenocarcinoma Cells JO - Rendiconti Lincei VL - 33 IS - 2 SP - 461 EP - 469 PY - 2022 ER - |